These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9254691)

  • 41. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists.
    Napier TC
    Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lesion of subthalamic nucleus in parkinsonian rats : effects of dopamine d(1) and d(2) receptor agonists on the neuronal activities of the substantia nigra pars reticulata.
    Park YS; Jeon MF; Lee BH; Chang JW
    J Korean Neurosurg Soc; 2007 Dec; 42(6):455-61. PubMed ID: 19096589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson's disease.
    Allers KA; Bergstrom DA; Ghazi LJ; Kreiss DS; Walters JR
    Exp Neurol; 2005 Jan; 191(1):104-18. PubMed ID: 15589517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease.
    Nakao N; Ogura M; Nakai K; Itakura T
    J Neurosci; 1998 Mar; 18(5):1806-17. PubMed ID: 9465005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
    Koller WC; Herbster G
    Clin Neuropharmacol; 1988 Jun; 11(3):221-31. PubMed ID: 3261198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M; Danek L; Smiałowski A
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
    Maslowski RJ; Napier TC
    Eur J Pharmacol; 1991 Jul; 200(1):103-12. PubMed ID: 1685119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
    Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S
    Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRs.
    Zhou C; Gu W; Wu H; Yan X; Deshpande P; Xiao C; Lester HA
    Neuropharmacology; 2019 Apr; 148():220-228. PubMed ID: 30660626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.
    Chetrit J; Taupignon A; Froux L; Morin S; Bouali-Benazzouz R; Naudet F; Kadiri N; Gross CE; Bioulac B; Benazzouz A
    J Neurosci; 2013 Sep; 33(37):14840-9. PubMed ID: 24027284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions.
    Strömberg I; Bickford-Wimer P
    Brain Res; 1991 Nov; 564(2):279-85. PubMed ID: 1687374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects.
    Walters JR; Bergstrom DA; Carlson JH; Chase TN; Braun AR
    Science; 1987 May; 236(4802):719-22. PubMed ID: 2953072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effect of subthalamic nucleus ablation on dopamine D1 and D2 agonist-induced rotation in 6-hydroxydopamine-lesioned rats.
    Anderson JJ; Chase TN; Engber TM
    Brain Res; 1992 Aug; 588(2):307-10. PubMed ID: 1356592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study.
    Carlson JH; Bergstrom DA; Walters JR
    Brain Res; 1987 Jan; 400(2):205-18. PubMed ID: 2880637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions.
    Mehta A; Thermos K; Chesselet MF
    Synapse; 2000 Sep; 37(4):298-307. PubMed ID: 10891867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Supersensitization of intrastriatal dopamine receptors involved in opposite regulation of acetylcholine release in Parkinson's model rats.
    Sato K; Ueda H; Okumura F; Misu Y
    Neurosci Lett; 1994 May; 173(1-2):59-62. PubMed ID: 7936424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats.
    Aristieta A; Ruiz-Ortega JA; Miguelez C; Morera-Herreras T; Ugedo L
    Neurobiol Dis; 2016 May; 89():88-100. PubMed ID: 26852950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.